This study assessed the Hr QoL (Health related Quality of life) of subjects with mild to
moderate AD, who received ARICEPT under usual clinical practice.
- Diagnosis of Alzheimer's Disease
- There are no exclusion criteria
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center
Pfizer Clinical Trials Contact Center
call now email
Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.